Negative Unintended Consequences as a Counterbalance to Innovation: The Macchiarini case as innovation governance at the interface between scientific research and clinical practic. McKelvey, M. & Saemundsson, R. J. In GEOINNO2020 Conference Proceedings. University of Stavanger. abstract bibtex Innovation processes – as well as scientific research and technological development – rely upon a continuous process of generating new knowledge, arising from collaboration across a variety of private actors like firms, societal actors like universities, NGOs and professional societies, as well as public actors like government agencies (Fagerberg and Mowery, 2006). Developing new areas of scientific research will help society in the long run, but equally important are the uses of that knowledge in order to implement ideas, translate research into practise, and more generally, find ways of societal impact. Hence, the positive outcomes of these innovation processes benefit society in the long-run through new products, services, and organizational forms. Therefore, public policy to stimulate science, technology and innovation is usually designed to stimulate novelty, due to the potential future benefits for society (Edler and Fagerberg 2017). This view stresses the positive side of innovation. But in recent years, a number of studies have focused upon the negative consequences, risks or “dark side of innovation” (Nightingale 2004; Stirling 2017), whereby increasing public concerns about risks have led to demands for more inclusive and transparent innovation processes (Stilgoe et al 2013). Our three-year qualitative study analyses processes of innovation governance, within an empirical context of negative unintended consequences, namely scientific misconduct, in the specific setting at the interface between biomedical scientific research and clinical practice.
@inproceedings{mckelvey_negative_2020,
location = {Stavanger, Norway},
title = {Negative Unintended Consequences as a Counterbalance to Innovation: The Macchiarini case as innovation governance at the interface between scientific research and clinical practic},
abstract = {Innovation processes – as well as scientific research and technological development – rely upon a continuous process of generating new knowledge, arising from collaboration across a variety of private actors like firms, societal actors like universities, {NGOs} and professional societies, as well as public actors like government agencies (Fagerberg and Mowery, 2006). Developing new areas of scientific research will help society in the long run, but equally important are the uses of that knowledge in order to implement ideas, translate research into practise, and more generally, find ways of societal impact. Hence, the positive outcomes of these innovation processes benefit society in the long-run through new products, services, and organizational forms. Therefore, public policy to stimulate science, technology and innovation is usually designed to stimulate novelty, due to the potential future benefits for society (Edler and Fagerberg 2017). This view stresses the positive side of innovation. But in recent years, a number of studies have focused upon the negative consequences, risks or “dark side of innovation” (Nightingale 2004; Stirling 2017), whereby increasing public concerns about risks have led to demands for more inclusive and transparent innovation processes (Stilgoe et al 2013). Our three-year qualitative study analyses processes of innovation governance, within an empirical context of negative unintended consequences, namely scientific misconduct, in the specific setting at the interface between biomedical scientific research and clinical practice.},
eventtitle = {Geography of Innovation Conference},
booktitle = {{GEOINNO}2020 Conference Proceedings},
publisher = {University of Stavanger},
author = {{McKelvey}, Maureen and Saemundsson, Rögnvaldur J.},
date = {2020-01},
}
Downloads: 0
{"_id":"eWZuk7S4Zgo2EWAmk","bibbaseid":"mckelvey-saemundsson-negativeunintendedconsequencesasacounterbalancetoinnovationthemacchiarinicaseasinnovationgovernanceattheinterfacebetweenscientificresearchandclinicalpractic","author_short":["McKelvey, M.","Saemundsson, R. J."],"bibdata":{"bibtype":"inproceedings","type":"inproceedings","location":"Stavanger, Norway","title":"Negative Unintended Consequences as a Counterbalance to Innovation: The Macchiarini case as innovation governance at the interface between scientific research and clinical practic","abstract":"Innovation processes – as well as scientific research and technological development – rely upon a continuous process of generating new knowledge, arising from collaboration across a variety of private actors like firms, societal actors like universities, NGOs and professional societies, as well as public actors like government agencies (Fagerberg and Mowery, 2006). Developing new areas of scientific research will help society in the long run, but equally important are the uses of that knowledge in order to implement ideas, translate research into practise, and more generally, find ways of societal impact. Hence, the positive outcomes of these innovation processes benefit society in the long-run through new products, services, and organizational forms. Therefore, public policy to stimulate science, technology and innovation is usually designed to stimulate novelty, due to the potential future benefits for society (Edler and Fagerberg 2017). This view stresses the positive side of innovation. But in recent years, a number of studies have focused upon the negative consequences, risks or “dark side of innovation” (Nightingale 2004; Stirling 2017), whereby increasing public concerns about risks have led to demands for more inclusive and transparent innovation processes (Stilgoe et al 2013). Our three-year qualitative study analyses processes of innovation governance, within an empirical context of negative unintended consequences, namely scientific misconduct, in the specific setting at the interface between biomedical scientific research and clinical practice.","eventtitle":"Geography of Innovation Conference","booktitle":"GEOINNO2020 Conference Proceedings","publisher":"University of Stavanger","author":[{"propositions":[],"lastnames":["McKelvey"],"firstnames":["Maureen"],"suffixes":[]},{"propositions":[],"lastnames":["Saemundsson"],"firstnames":["Rögnvaldur","J."],"suffixes":[]}],"date":"2020-01","bibtex":"@inproceedings{mckelvey_negative_2020,\n\tlocation = {Stavanger, Norway},\n\ttitle = {Negative Unintended Consequences as a Counterbalance to Innovation: The Macchiarini case as innovation governance at the interface between scientific research and clinical practic},\n\tabstract = {Innovation processes – as well as scientific research and technological development – rely upon a continuous process of generating new knowledge, arising from collaboration across a variety of private actors like firms, societal actors like universities, {NGOs} and professional societies, as well as public actors like government agencies (Fagerberg and Mowery, 2006). Developing new areas of scientific research will help society in the long run, but equally important are the uses of that knowledge in order to implement ideas, translate research into practise, and more generally, find ways of societal impact. Hence, the positive outcomes of these innovation processes benefit society in the long-run through new products, services, and organizational forms. Therefore, public policy to stimulate science, technology and innovation is usually designed to stimulate novelty, due to the potential future benefits for society (Edler and Fagerberg 2017). This view stresses the positive side of innovation. But in recent years, a number of studies have focused upon the negative consequences, risks or “dark side of innovation” (Nightingale 2004; Stirling 2017), whereby increasing public concerns about risks have led to demands for more inclusive and transparent innovation processes (Stilgoe et al 2013). Our three-year qualitative study analyses processes of innovation governance, within an empirical context of negative unintended consequences, namely scientific misconduct, in the specific setting at the interface between biomedical scientific research and clinical practice.},\n\teventtitle = {Geography of Innovation Conference},\n\tbooktitle = {{GEOINNO}2020 Conference Proceedings},\n\tpublisher = {University of Stavanger},\n\tauthor = {{McKelvey}, Maureen and Saemundsson, Rögnvaldur J.},\n\tdate = {2020-01},\n}\n\n","author_short":["McKelvey, M.","Saemundsson, R. J."],"key":"mckelvey_negative_2020","id":"mckelvey_negative_2020","bibbaseid":"mckelvey-saemundsson-negativeunintendedconsequencesasacounterbalancetoinnovationthemacchiarinicaseasinnovationgovernanceattheinterfacebetweenscientificresearchandclinicalpractic","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"inproceedings","biburl":"https://raw.githubusercontent.com/kelvey/kelvey.github.io/master/testLibrary.bib","dataSources":["ju6c6CDovtuyuQ27g"],"keywords":[],"search_terms":["negative","unintended","consequences","counterbalance","innovation","macchiarini","case","innovation","governance","interface","between","scientific","research","clinical","practic","mckelvey","saemundsson"],"title":"Negative Unintended Consequences as a Counterbalance to Innovation: The Macchiarini case as innovation governance at the interface between scientific research and clinical practic","year":null}